REBYOTA
REBYOTA (Fecal Microbiota Live-JSLM) is an FDA-approved live microbiota therapy indicated for the prevention of recurrent Clostridioides difficile infection (rCDI) in adults following successful antibiotic treatment. Each pack contains 1×150 mL enema, providing a standardized preparation of live, healthy gut bacteria to help restore a balanced intestinal microbiome.
Administered rectally (enema) under professional supervision, REBYOTA works by repopulating the gut with beneficial microorganisms, reducing the risk of future C. difficile infections, and promoting overall gastrointestinal health. This therapy represents a novel, microbiome-based approach to managing recurrent infections.
InfusionMed USA, located in Carrollton, Texas, supplies REBYOTA to hospitals, gastroenterology clinics, and specialty infusion centers across Dallas, McKinney, Frisco, Plano, Lewisville, The Colony, and surrounding North Texas regions. We ensure proper cold-chain storage, careful handling, and timely delivery for all microbiota-based therapies.
For professional use only. Administer as directed by a healthcare provider.
Download Form